Spleen cells from 1 to 2 individual mice were pooled, and seeded in triplicates in 96-well plates at 2 × 105 cells/well in RPMI 1640 medium (200 μl volume) containing heat-inactivated fetal calf serum (10%), penicillin/streptomycin, glutamine, and HEPES (25 mM), at 37 °C and 5% CO2 (all from Sigma-Aldrich). Cells were stimulated for 6 days with 15-mer peptides (10 μM; resulting in DMSO concentration 0.1%), a combination of anti-CD3 and anti-CD28 antibodies (positive control, 3 μg and 2 μg/ml; clones 145–2C11 and 37.51; eBioscience, San Diego, CA), endotoxin-free ovalbumin (negative control), recombinant influenza A hemagglutinin, neuraminidase or nucleoprotein (all 10 μg/ml). For each stimulation, two plates were run in parallel (from two different spleen cell pools).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.